Abstracts tagged "positron emission tomography (PET) and vasculitis"

Abstract Number: 817 • 2017 ACR/ARHP Annual Meeting
Extension of Affected Vascular Territories in Secondary Aortitis Is Associated to Different Clinical Subtypes?
Nuria Vegas-Revenga¹, Javier Loricera¹, Diana Prieto Peña¹, Isabel Martínez-Rodríguez¹, Jose Ignacio Banzo², Monica Calderón Goercke³, Jesus Gonzalez- Vela¹, Jose L. Hernández¹, Vanesa Calvo-Río¹, Lucia C. Domínguez-Casas¹, José Luis Martín-Varillas³, Belén Atienza-Mateo³, MC Gonzalez-Vela¹, Miguel Angel González-Gay¹ and Ricardo Blanco³, ¹Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Nuclear Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain
Background/Purpose: Aortitis is characterized by inflammation of the aortic wall. Aortitis may be associated with different conditions. Our aim was to assess if the different…
Abstract Number: 1845 • 2017 ACR/ARHP Annual Meeting
Comparison of Magnetic Resonance Angiography (MRA) and 18f-Fluorodeoxyglucose Positron Emission Tomography (PET) in Large Vessel Vasculitis
Kaitlin A. Quinn^1,2, Ashkan Malayeri³, Mark Ahlman³, Armin Bagheri⁴, Robert Evers⁵, Ali Cahid Civelek³, Elaine Novakovich⁶ and Peter C. Grayson⁷, ¹Rheumatology, MedStar Georgetown University Hospital, Washington, DC, ²NIAMS/NIH, Bethesda, MD, ³Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, ⁴Vasculitis Translational Research Program, NIAMS, NIH, Bethesda, MD, ⁵NIH, Bethesda, MD, ⁶Systemic Autoimmunity Branch, NIAMS, National Institutes of Health, Bethesda, MD, ⁷National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD
Background/Purpose: Magnetic resonance imaging (MRI) and 18F-fluorodeoxyglucose positron emission tomography (PET) may provide unique or redundant information in large vessel vasculitis (LVV). The study objective…
Abstract Number: 260 • 2017 ACR/ARHP Annual Meeting
Use of Positron Emission Tomography for the Diagnosis of Aortitis. a Study of 170 Patients from a Single Center
Lucia C. Domínguez-Casas¹, Javier Loricera¹, Diana Prieto Peña¹, Isabel Martínez-Rodríguez², Jose Ignacio Banzo², Monica Calderón Goercke¹, Vanesa Calvo-Río¹, Nuria Vegas-Revenga¹, MC Gonzalez-Vela³, Jesus Gonzalez- Vela⁴, José Luis Martín-Varillas¹, Belén Atienza-Mateo¹, Jose L. Hernández⁵, Miguel Angel González-Gay¹ and Ricardo Blanco¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Nuclear Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Pathology Anatomy, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁴Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁵Internal Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain
Background/Purpose: Aortitis is the inflammation of the aortic wall. This entity is often under-recognised because most of its manifestations are non-specific. PET/CT scan plays an…
Abstract Number: 809 • 2017 ACR/ARHP Annual Meeting
Prevalence and Distribution of Vascular FDG Uptake on Positron Emission Tomography (PET)-CT in Patients Suspected of Having Giant Cell Arteritis – Interim Results from the Giant Cell Arteritis and PET Scan (GAPS) Study
Anthony Sammel¹, Edward Hsiao², Katherine Nguyen³, Geoffrey Schembri², Leslie Schrieber³, Peter Youssef⁴, Beatrice Janssen³ and Rodger Laurent³, ¹Rheumatology, Royal North Shore Hospital, St Leonards, Sydney, Australia, ²Royal North Shore Hospital, St Leonards, Australia, ³Royal North Shore Hospital, St Leonards, Sydney, Australia, ⁴Royal Prince Alfred Hospital, Camperdown, Sydney, Australia
Background/Purpose: Positron emission tomography (PET)-CT scan can assess large vessel vasculitis in giant cell arteritis (GCA). It has a reported sensitivity of 80% for biopsy…
Abstract Number: 1336 • 2015 ACR/ARHP Annual Meeting
To PET or Not to PET in General Rheumatology Practice
Kavina Shah, Roshni Doshi, Joshua Balogun-Lynch, Henry Penn and Shahir Hamdulay, Rheumatology, Northwick Park Hospital, Middlesex, United Kingdom
Background/Purpose: Fluoro-deoxy-glucose positron emission tomography with computerised tomography (PET/CT) is an imaging modality which identifies tissues with high metabolic activity. It is used in the…
Abstract Number: 2350 • 2012 ACR/ARHP Annual Meeting
Similarities Exceeds Differences in the Pattern of Joint and Vascular Positron Emission/Computed Tomography Uptake in Polymyalgia Rheumatica and Giant Cell Arteritis
Dario Camellino¹, Silvia Morbelli², Francesco Paparo³, Michela Massollo², Gianmario Sambuceti⁴ and Marco A. Cimmino⁵, ¹Dipartimento Medicina Interna, Clinica Reumatologica, Genova, Italy, ²Dipartimento Medicina Interna, Medicina Nucleare, Genova, Italy, ³Radiology Unit, E.O. Ospedali Galliera, Genoa, Italy, ⁴Dipartimento di Medicina Interna, Medicina Nucleare, Genova, Italy, ⁵Department of Internal Medicine, Academic Unit of Clinical Rheumatology, University of Genova, Genova, Italy
Background/Purpose: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are two frequent overlapping diseases. The purpose of this work is to examine the relationship between…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].